PharmaEngine Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Hong-Ren Wang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.02% |
| Management average tenure | no data |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
Would PharmaEngine, Inc. (GTSM:4162) Be Valuable To Income Investors?
Mar 30
How Much Did PharmaEngine's(GTSM:4162) Shareholders Earn From Share Price Movements Over The Last Five Years?
Feb 18Is PharmaEngine, Inc.'s (GTSM:4162) Stock On A Downtrend As A Result Of Its Poor Financials?
Jan 14
We're Not Counting On PharmaEngine (GTSM:4162) To Sustain Its Statutory Profitability
Dec 10CEO
Hong-Ren Wang
3.3yrs
Tenure
Mr. Hong-Ren Wang, Ph D., is President of PharmaEngine, Inc. since January 20, 2021 and serves as Chief Executive Officer. Mr. Wang holds Ph.D. degree in Materials Science and Engineering from Massachusett...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Representative Director | no data | no data | no data | |
| Representative Director | 6.3yrs | NT$2.33m | no data | |
| Representative Director | 6yrs | NT$2.33m | no data | |
| Independent Director | 4.9yrs | NT$1.73m | 0.0021% NT$ 283.0k | |
| Director | 2.8yrs | NT$816.00k | no data | |
| Independent Director | 2.8yrs | NT$596.00k | no data | |
| Independent Director | no data | no data | no data | |
| Representative Director | no data | no data | no data | |
| Chairman | no data | no data | no data |
4.9yrs
Average Tenure
Experienced Board: 4162's board of directors are considered experienced (4.9 years average tenure).